Pneumococcal Vaccination

Below you will find the groups that will receive subsidies for the various vaccines.

You can also read more about invasive pneumococcal disease and vaccination against pneumococci on the State Serum Institute's website.

The 13-valent conjugated pneumococcal vaccine

See the description of the vaccine at Statens Serum Institut: Pneumococcal vaccine 13-valent (Danish language information)

In connection with the entry into force of a free vaccination program with the 23-valent pneumococcal vaccine on April 22, 2020, the National Board of Health has begun to re-evaluate which groups should continue to have a conditional grant for the 13-valent vaccine. Until this assessment is completed, the following groups may continue to receive grants.

People with:

• Performed/planned splenectomy, organ transplant or cochlear implantation
• Lack of spleen function (eg after radiation)
• Liquorlækage
• Previously invasive pneumococcal disease
• Immunosuppression (eg, HIV infection or lymphoma)
• Chronic obstructive pulmonary disease (COPD) over 65 or at FEV1 of less than 40% of the expected
• Heart failure (heart failure) over 65 years
• Chronic heart disease over the age of 65 (excluding people with hypertension)
• Diabetes mellitus over 65 years
• Chronic kidney disease over 65 years
• Chronic liver disease over 65 years
• Asthma over 65 years
• Chronic bronchitis over 65 years.
  

People under 18 with:

• Cyanotic heart disease
• Heart failure
• Palliative surgery for heart disease
• Hemodynamically significant residue after cardiac surgery
• Chronic lung disease (eg cystic fibrosis)
• Hypodynamic respiratory insufficiency
• Nephrotic syndrome
• Immune defects, exclusive agammaglobulinemia, and SCID.
  

The vaccine is also offered free of charge to all children as part of the Danish child vaccination program.

The 23-valent pneumococcal vaccine

See the description of the vaccine at Statens Serum Institut: Pneumococcal vaccine 23-valent (Danish language information).

On April 22, 2020, a free vaccination program with the 23-valent vaccine came into effect, therefore, this vaccine will no longer be subsidized with the exception of a single group:

• People with chronic obstructive pulmonary disease (COPD) with FEV1 of less than 40% of expected.